Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging.

Thu MS, Bryant LH, Coppola T, Jordan EK, Budde MD, Lewis BK, Chaudhry A, Ren J, Varma NR, Arbab AS, Frank JA.

Nat Med. 2012 Feb 26;18(3):463-7. doi: 10.1038/nm.2666.

2.

Potential role of tracing stem cell transplantation and effects on the immune cell function of ferumoxytol combining with heparin and protamine in vivo/in vitro.

Zhao J, Guan X, Liu Y, Piao H, Liu R, Zhou X, Sun B, Du Y, Liu J.

Cell Biol Int. 2017 Apr;41(4):423-432. doi: 10.1002/cbin.10737. Epub 2017 Feb 20.

PMID:
28150359
3.

Physicochemical characterization of ferumoxytol, heparin and protamine nanocomplexes for improved magnetic labeling of stem cells.

Bryant LH Jr, Kim SJ, Hobson M, Milo B, Kovacs ZI, Jikaria N, Lewis BK, Aronova MA, Sousa AA, Zhang G, Leapman RD, Frank JA.

Nanomedicine. 2017 Feb;13(2):503-513. doi: 10.1016/j.nano.2016.07.011. Epub 2016 Aug 9.

PMID:
27520728
4.

Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical use.

Gutova M, Frank JA, D'Apuzzo M, Khankaldyyan V, Gilchrist MM, Annala AJ, Metz MZ, Abramyants Y, Herrmann KA, Ghoda LY, Najbauer J, Brown CE, Blanchard MS, Lesniak MS, Kim SU, Barish ME, Aboody KS, Moats RA.

Stem Cells Transl Med. 2013 Oct;2(10):766-75. doi: 10.5966/sctm.2013-0049. Epub 2013 Sep 6.

5.

Feasibility of islet magnetic resonance imaging using ferumoxytol in intraportal islet transplantation.

Jin SM, Oh SH, Oh BJ, Shim W, Choi JM, Yoo D, Hwang YH, Lee JH, Lee DY, Kim JH.

Biomaterials. 2015 Jun;52:272-80. doi: 10.1016/j.biomaterials.2015.02.055. Epub 2015 Feb 28.

PMID:
25818433
6.

Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells.

Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, Frank JA.

NMR Biomed. 2005 Dec;18(8):553-9.

PMID:
16229060
7.

In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging.

Wu YJ, Muldoon LL, Varallyay C, Markwardt S, Jones RE, Neuwelt EA.

Am J Physiol Cell Physiol. 2007 Nov;293(5):C1698-708. Epub 2007 Sep 26.

8.

Iron administration before stem cell harvest enables MR imaging tracking after transplantation.

Khurana A, Chapelin F, Beck G, Lenkov OD, Donig J, Nejadnik H, Messing S, Derugin N, Chan RC, Gaur A, Sennino B, McDonald DM, Kempen PJ, Tikhomirov GA, Rao J, Daldrup-Link HE.

Radiology. 2013 Oct;269(1):186-97. doi: 10.1148/radiol.13130858. Epub 2013 Jul 12.

9.

Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI.

Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA.

Blood. 2004 Aug 15;104(4):1217-23. Epub 2004 Apr 20.

10.

Labeling stem cells with ferumoxytol, an FDA-approved iron oxide nanoparticle.

Castaneda RT, Khurana A, Khan R, Daldrup-Link HE.

J Vis Exp. 2011 Nov 4;(57):e3482. doi: 10.3791/3482.

11.

Optimization and validation of FePro cell labeling method.

Janic B, Rad AM, Jordan EK, Iskander AS, Ali MM, Varma NR, Frank JA, Arbab AS.

PLoS One. 2009 Jun 11;4(6):e5873. doi: 10.1371/journal.pone.0005873.

12.

Hematopoietic stem cell (CD34+) uptake of superparamagnetic iron oxide is enhanced by but not dependent on a transfection agent.

England TJ, Bath PM, Abaei M, Auer D, Jones DR.

Cytotherapy. 2013 Mar;15(3):384-90. doi: 10.1016/j.jcyt.2012.10.016.

PMID:
23579062
13.

Magnetic Resonance Imaging of Ferumoxytol-Labeled Human Mesenchymal Stem Cells in the Mouse Brain.

Lee NK, Kim HS, Yoo D, Hwang JW, Choi SJ, Oh W, Chang JW, Na DL.

Stem Cell Rev. 2017 Feb;13(1):127-138. doi: 10.1007/s12015-016-9694-0.

14.

[Sinerem labeling and MRI tracking of neural stem cells in vivo and in vitro].

Chen ZC, Xu RX, Yang ZJ, Fan J, Xiu JG, Dai GH, Jiang XD, Wei L, Lei H.

Nan Fang Yi Ke Da Xue Xue Bao. 2007 May;27(5):611-5. Chinese.

15.

Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging.

Jasmin, Torres AL, Nunes HM, Passipieri JA, Jelicks LA, Gasparetto EL, Spray DC, Campos de Carvalho AC, Mendez-Otero R.

J Nanobiotechnology. 2011 Feb 9;9:4. doi: 10.1186/1477-3155-9-4. Erratum in: J Nanobiotechnology. 2011;9:12. Dosage error in article text.

16.

In vivo MRI tracking of iron oxide nanoparticle-labeled human mesenchymal stem cells in limb ischemia.

Li XX, Li KA, Qin JB, Ye KC, Yang XR, Li WM, Xie QS, Jiang ME, Zhang GX, Lu XW.

Int J Nanomedicine. 2013;8:1063-73. doi: 10.2147/IJN.S42578. Epub 2013 Mar 12.

17.

Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI.

Khurana A, Nejadnik H, Chapelin F, Lenkov O, Gawande R, Lee S, Gupta SN, Aflakian N, Derugin N, Messing S, Lin G, Lue TF, Pisani L, Daldrup-Link HE.

Nanomedicine (Lond). 2013 Dec;8(12):1969-83. doi: 10.2217/nnm.12.198. Epub 2013 Mar 27.

18.

Magnetic Resonance Imaging of Iron Oxide-Labeled Human Embryonic Stem Cell-Derived Cardiac Progenitors.

Skelton RJ, Khoja S, Almeida S, Rapacchi S, Han F, Engel J, Zhao P, Hu P, Stanley EG, Elefanty AG, Kwon M, Elliott DA, Ardehali R.

Stem Cells Transl Med. 2016 Jan;5(1):67-74. doi: 10.5966/sctm.2015-0077. Epub 2015 Nov 18.

19.

Low molecular weight alkyl-polycation wrapped magnetite nanoparticle clusters as MRI probes for stem cell labeling and in vivo imaging.

Liu G, Wang Z, Lu J, Xia C, Gao F, Gong Q, Song B, Zhao X, Shuai X, Chen X, Ai H, Gu Z.

Biomaterials. 2011 Jan;32(2):528-37. doi: 10.1016/j.biomaterials.2010.08.099. Epub 2010 Sep 25.

PMID:
20869767
20.

A magnetofluorescent nanoparticle for ex-vivo cell labeling by covalently linking the drugs protamine and Feraheme.

Chen S, Alcantara D, Josephson L.

J Nanosci Nanotechnol. 2011 Apr;11(4):3058-64.

PMID:
21776671

Supplemental Content

Support Center